483 related articles for article (PubMed ID: 22221178)
21. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
[TBL] [Abstract][Full Text] [Related]
22. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
[TBL] [Abstract][Full Text] [Related]
23. Effect of fresh-frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities.
Abdel-Wahab OI; Healy B; Dzik WH
Transfusion; 2006 Aug; 46(8):1279-85. PubMed ID: 16934060
[TBL] [Abstract][Full Text] [Related]
24. Hyperfibrinolysis Is an Important Cause of Early Hemorrhage in Patients with Acute Promyelocytic Leukemia.
Song YH; Qiao C; Xiao LC; Zhang R; Lu H-
Med Sci Monit; 2018 May; 24():3249-3255. PubMed ID: 29771870
[TBL] [Abstract][Full Text] [Related]
25. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia.
Higuchi T; Shimizu T; Mori H; Niikura H; Omine M
Hematol Oncol; 1997 Nov; 15(4):209-17. PubMed ID: 9722892
[TBL] [Abstract][Full Text] [Related]
26. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
Rinsho Byori; 1993 Jun; 41(6):719-25. PubMed ID: 8361040
[TBL] [Abstract][Full Text] [Related]
27. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
28. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
[TBL] [Abstract][Full Text] [Related]
29. Value of the FDP/FIB ratio in predicting early severe bleeding events in patients with newly diagnosed acute promyelocytic leukemia.
Li S; Gao Y; Li F; Zheng Y; Su Y
Ann Hematol; 2023 Apr; 102(4):787-794. PubMed ID: 36750485
[TBL] [Abstract][Full Text] [Related]
30. Disseminated intravascular coagulation in acute leukemia.
Barbui T; Falanga A
Semin Thromb Hemost; 2001 Dec; 27(6):593-604. PubMed ID: 11740683
[TBL] [Abstract][Full Text] [Related]
31. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors for differentiating thrombohemorrhagic disorders in high-risk acute promyelocytic leukemia.
Xiao M; Zhou P; Liu Y; Wei S; Li D; Li W; Niu X; Niu J; Zhang Y; Cao W; Liu B; Wang X; Bai Y; Sun K
Thromb Res; 2022 Feb; 210():33-41. PubMed ID: 34998209
[TBL] [Abstract][Full Text] [Related]
33. The pathophysiology and treatment of hemorrhagic syndrome of acute promyelocytic leukemia.
Rodeghiero F; Castaman G
Leukemia; 1994; 8 Suppl 2():S20-6. PubMed ID: 7815832
[TBL] [Abstract][Full Text] [Related]
34. Massive blood transfusion in a tertiary referral hospital. Clinical outcomes and haemostatic complications.
Harvey MP; Greenfield TP; Sugrue ME; Rosenfeld D
Med J Aust; 1995 Oct; 163(7):356-9. PubMed ID: 7565259
[TBL] [Abstract][Full Text] [Related]
35. Coagulation disorders in patients with severe leptospirosis are associated with severe bleeding and mortality.
Wagenaar JF; Goris MG; Partiningrum DL; Isbandrio B; Hartskeerl RA; Brandjes DP; Meijers JC; Gasem MH; van Gorp EC
Trop Med Int Health; 2010 Feb; 15(2):152-9. PubMed ID: 20002620
[TBL] [Abstract][Full Text] [Related]
36. [Clinical evaluation of Chinese disseminated intravascular coagulation scoring system (version 2017) in patients with acute promyelocytic leukemia].
Huang YT; Liu XF; Fu RF; Chen YF; Liu W; Xue F; Zhang L; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):480-484. PubMed ID: 30032565
[No Abstract] [Full Text] [Related]
37. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
38. [Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].
Lu X; Li W; Wang G; Wang Q; Jiang Y; Gao J; Zhao X; Xu L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):92-6. PubMed ID: 25665605
[TBL] [Abstract][Full Text] [Related]
39. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH
Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464
[TBL] [Abstract][Full Text] [Related]
40. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
Tallman MS; Abutalib SA; Altman JK
Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]